Comparative efficacy and tolerability of drotaverine 80 mg and ibuprofen 400 mg in patients with primary dysmenorrhea – Protocol DOROTA
Journal Title: Postępy Nauk Medycznych - Year 2010, Vol 23, Issue 8
Abstract
Objective: To compare efficacy and tolerability of drotaverine 80 mg and ibuprofen 400 mg in patients with primary dysmenorrhea.Materials and methods:Nine-month, multicenter (11 study centers in Poland), randomised, double-blind, phase III study conducted in two parallel group, included 345 women between 18 and 35 years, suffering from primary dysmenorrhea for at least 6 months with presence of moderate to severe pain in each of the last 3 cycles. Patients had regular menstrual cycles (25-35 days) and used an adequate barrier contraception method with a negative pregnancy test before randomization. Patients were given 80mg drotaverine or 400mg ibuprofen and asked to assess the pain intensity rated on a 4-point categorical scale (0=none, 1=mild, 2=moderate, 3=severe) at baseline and 0.5, 1, 2, 3, 4, 5 and 6 hours after the first intake and evaluate the efficacy (excellent, good, fair, poor) at the end of the treatment period.. Results:Although the patient’s global assessment of the tolerability was significantly better (p=0.02) with ibuprofen 400mg (excellent or good: 86.8%) than with drotaverin 80mg (excellent or good: 78.4%), no relevant difference between the both groups was observed for frequency, nature, intensity and causality of the reported adverse events. Changes in pain intensity were calculated for each patient at each period according to her baseline value. The weighted sum of pain intensity differences over the 6-hour observation period (SPID-6) was calculated. The pain intensity before the first intake was comparable in the two groups.At the time-points, the decrease of pain was always greater in the ibuprofen 400mg group than in the drotaverine 80mg group and was maximum at the 4th hour in the drotaverine 80mg group (-1.2 ± 1.18) and at the 3rd hour in the ibuprofen 400mg group (1.7 ± 0.99).Conclusions:Drotaverin 80 mg is effective and slightly slower in decreasing menstrual pain then 400 mg ibuprofen.Both drugs were well tolerated. The reported emergent adverse events were known drug reactions or expected events in patients suffering from dysmenorrhea.
Authors and Affiliations
Romuald Dębski, Tomasz Niemiec, Marzena Mazurek
Keywords
Related Articles
- EP ID EP53970
- DOI -
- Views 169
- Downloads 1
Przetoka tętniczo-żylna u pacjentów dializowanych w starszym wieku
<b>Wstęp.</b> Starzenie się społeczeństwa i włączanie do hemodializ coraz starszych pacjentów wymagają zapewnienia sprawnego i bezpiecznego dostępu naczyniowego w schorowanej grupie chorych.&a...
Infekcyjne zapalenie wsierdzia na zastawce mitralnej jako powikłanie w przebiegu kardiomiopatii przerostowej zawężającej – wciąż aktualny problem
Infekcyjne zapalenie wsierdzia w przebiegu kardiomiopatii przerostowej występuje rzadko. Doniesienia piśmiennictwa zawierają głównie opisy przypadków klinicznych, dlatego też ocena stopnia ryzyka rozwoju infekcyjnego zap...
Smarts as a problem of emergency medicine
The use of drugs is complex, nonhomogeneous and dynamic phenomenon. From time to time new trends appears on the narcotics scene and simultaneously other behavior's models disapeared. Depends of study persons who take dru...
Diagnostyka obrazowa w zaburzeniach metabolicznych. Od metod tradycyjnych do nowoczesnych
Częstość występowania zaburzeń metabolicznych, zwłaszcza otyłości i powiązanych z nią zaburzeń wchodzących w skład zespołu metabolicznego, wykazuje stałą tendencję wzrostową i obecnie dotyka już milionów ludzi na świecie...
Spoligotype-defined population structure of drug-resistant Mycobacterium tuberculosis isolates in Eastern Poland
Introduction. The most detrimental impact on the epidemiology of tuberculosis (TB) in Poland may have the spread of tubercle bacilli from outside the country. This is because Poland is geographically situated in close pr...